Label: EVERTOX SPECIAL BATH PREPARATIONS- silicon dioxide powder

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated January 11, 2015

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    monzonite

  • INACTIVE INGREDIENT

    silica compound


  • PURPOSE

    relieve atopic symptom (itching, inflammation and pain), relieve ring worm, relieve stress



  • KEEP OUT OF REACH OF CHILDREN

    keep out of reach of the children

  • INDICATIONS & USAGE

    apply on evertox per 100 liter approximately
    application part: whole body
    apply for 5~30 minutes preferably during bath
    keep cool and dry after use


  • WARNINGS

    do not open the case, in case the case opened by user fault, please keep the ingredients away immediately



  • DOSAGE & ADMINISTRATION

    for external use only

  • PRINCIPAL DISPLAY PANEL

    package label
  • INGREDIENTS AND APPEARANCE
    EVERTOX SPECIAL BATH PREPARATIONS 
    silicon dioxide powder
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69474-1001
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4) (SILICON DIOXIDE - UNII:ETJ7Z6XBU4) SILICON DIOXIDE20 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    SILVER (UNII: 3M4G523W1G)  
    SODIUM ALUMINIUM SILICATE (UNII: 058TS43PSM)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69474-1001-165 g in 1 BOTTLE
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other01/11/2015
    Labeler - KMTR Co., Ltd. (688263356)
    Registrant - KMTR Co., Ltd. (688263356)
    Establishment
    NameAddressID/FEIBusiness Operations
    KMTR Co., Ltd.688263356manufacture(69474-1001)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!